39 related articles for article (PubMed ID: 25068307)
1. Increased risk of nephrolithiasis: an emerging issue in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Chiarito M; Lattanzio C; D'Ascanio V; Capalbo D; Cavarzere P; Grandone A; Aiello F; Pepe G; Wasniewska M; Zoller T; Salerno M; Faienza MF
Endocrine; 2024 May; 84(2):727-734. PubMed ID: 38536547
[TBL] [Abstract][Full Text] [Related]
2. Nonclassical congenital adrenal hyperplasia: targets of treatment and transition.
McCann-Crosby B; Chen MJ; Lyons SK; Lin Y; Axelrad M; Dietrich JE; Sutton VR; Macias CG; Gunn S; Karaviti L
Pediatr Endocrinol Rev; 2014 Dec; 12(2):224-38. PubMed ID: 25581988
[TBL] [Abstract][Full Text] [Related]
3. Interdependence of right ventricular systolic function and left ventricular filling and its association with outcome for patients with pulmonary hypertension.
Motoji Y; Tanaka H; Fukuda Y; Sano H; Ryo K; Imanishi J; Miyoshi T; Sawa T; Mochizuki Y; Matsumoto K; Emoto N; Hirata K
Int J Cardiovasc Imaging; 2015 Apr; 31(4):691-8. PubMed ID: 25614330
[TBL] [Abstract][Full Text] [Related]
4. Markers of cardiac dysfunction in cognitive impairment and dementia.
Hilal S; Chai YL; Ikram MK; Elangovan S; Yeow TB; Xin X; Chong JY; Venketasubramanian N; Richards AM; Chong JPC; Lai MKP; Chen C
Medicine (Baltimore); 2015 Jan; 94(1):e297. PubMed ID: 25569645
[TBL] [Abstract][Full Text] [Related]
5. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
[TBL] [Abstract][Full Text] [Related]
6. Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy.
Pina C; Khattab A; Katzman P; Bruckner L; Andolina J; New M; Yau M
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):663-7. PubMed ID: 25427061
[TBL] [Abstract][Full Text] [Related]
7. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H; Frisén L; Norrby C; Hirschberg AL; Almqvist C; Nordenskjöld A; Nordenström A
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2715-21. PubMed ID: 25279502
[TBL] [Abstract][Full Text] [Related]
8. Ultralow-dose Dexamethasone to Preserve Endogenous Cortisol Stress Response in Nonclassical Congenital Adrenal Hyperplasia: A New Promising Treatment.
van der Kaay D; van den Akker E
Int J Endocrinol Metab; 2014 Jul; 12(3):e14657. PubMed ID: 25237318
[TBL] [Abstract][Full Text] [Related]
9. The frequency and the effects of 21-hydroxylase gene defects in congenital adrenal hyperplasia patients.
Kirac D; Guney AI; Akcay T; Guran T; Ulucan K; Turan S; Ergec D; Koc G; Eren F; Kaspar EC; Bereket A
Ann Hum Genet; 2014 Nov; 78(6):399-409. PubMed ID: 25227725
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of 78 patients with nonclassical 21-hydroxylase deficiency.
Liu E; Luo H; Zhou K; Zhang Y
Arch Gynecol Obstet; 2023 Sep; 308(3):871-882. PubMed ID: 36773044
[TBL] [Abstract][Full Text] [Related]
11. The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature.
Bird IM; Abbott DH
J Steroid Biochem Mol Biol; 2016 Oct; 163():136-46. PubMed ID: 27154414
[TBL] [Abstract][Full Text] [Related]
12. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
13. Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions.
Tuten A; Sahmay S; Oncul M; Acikgoz AS; Imamoglu M; Gurleyen HC; Senturk ML
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():121-5. PubMed ID: 24768424
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of late onset congenital adrenal hyperplasia].
Rouach M; Blumenfeld Z
Harefuah; 1993 Mar; 124(5):249-53, 320. PubMed ID: 8495912
[TBL] [Abstract][Full Text] [Related]
16. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
Sahmay S; Tuten A; Gurleyen H; Oncul M; Benian A; Tamer Erel C
Minerva Endocrinol; 2014 Sep; 39(3):215-22. PubMed ID: 25068307
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
